OSE Immunotherapeutics SA (EPA:OSE)
France · Delayed Price · Currency is EUR 5.34
-0.03 (-0.56%)
At close: Nov 28, 2025
OSE Immunotherapeutics Market Cap
OSE Immunotherapeutics has a market cap or net worth of €119.61 million as of November 28, 2025. Its market cap has decreased by -36.43% in one year.
Market Cap
119.61M
Enterprise Value
106.63M
Revenue
83.44M
Ranking
n/a
PE Ratio
3.65
Stock Price
€5.34
Market Cap Chart
Since March 30, 2015, OSE Immunotherapeutics's market cap has increased from 104.30M to 119.61M, an increase of 14.68%. That is a compound annual growth rate of 1.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 119.61M | -23.73% |
| Dec 31, 2024 | 156.83M | 94.71% |
| Dec 29, 2023 | 80.55M | -34.73% |
| Dec 30, 2022 | 123.40M | -34.26% |
| Dec 31, 2021 | 187.71M | 45.49% |
| Dec 31, 2020 | 129.02M | 133.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 142.36B |
| Sanofi | 104.35B |
| Sartorius Stedim Biotech | 20.17B |
| bioMérieux | 12.74B |
| Eurofins Scientific SE | 10.39B |
| Ipsen | 10.21B |
| ABIVAX Société Anonyme | 8.16B |
| Virbac | 3.08B |